Acura Pharmaceuticals Financial Activities - Other 2010-2021 | ACUR
Acura Pharmaceuticals financial activities - other from 2010 to 2021. Financial activities - other can be defined as the net amount of items a company reports that are too small to report separately. Additionally, this field holds the sum of items a company reports that cannot be assigned to any other standardized field in the financing activities section of the Cash Flows Statement.
Acura Pharmaceuticals Annual Financial Activities - Other
(Millions of US $) |
| 2021 |
$0 |
| 2020 |
$0 |
| 2019 |
$0 |
| 2018 |
$0 |
| 2017 |
$N/A |
| 2016 |
$N/A |
| 2015 |
$-1 |
| 2014 |
$-1 |
| 2013 |
$-1 |
| 2012 |
$-1 |
| 2011 |
$-2 |
| 2010 |
$N/A |
| 2009 |
$N/A |
| Sector |
Industry |
Market Cap |
Revenue |
| Medical |
Medical - Generic Drugs |
$0.001B |
$0.000B |
|
Halsey Drug Company, Inc. is engaged in the manufacture, sale and distribution of generic drugs. A generic drug is the chemical and therapeutic equivalent of a brand-name drug for which patent protection has expired. The company sells its generic drug products under its Halsey label and under private-label arrangements with drugstore chains and drug wholesalers.
|
